Post-apocalyptic Brad Pitt film shoots at Pfizer site; Keppra generics eat into UCB sales growth;

@FiercePharma: Korean pharma stocks are riding an updraft of M&A speculation. Keunwha, Hondok way up ... anyone shopping? More | Follow @FiercePharma

> The Brad PItt vehicle World War Z moved into Pfizer's ($PFE) shrinking R&D facility in Sandwich, England, for some post-apocalyptic film shooting. Report

> Generic competition for its seizure drug Keppra held back sales growth at UCB, but the anti-inflammatory drug Cimzia helped make up the gap. Report

> Many drugmakers shuttered plants and other facilities on the East Coast as Hurricane Sandy barreled through. Report

> Dr. Reddy's Laboratories posted better-than-expected profits as new generics drove a 47% increase in North American sales. Report

> Watson Pharmaceuticals ($WPI), cleaning house as it merges with Swiss-based Actavis, said it has sold its Rugby over-the-counter business to Harvard Drug Group for $117 million. Report

> Shanghai Fosun Pharma shares made an inauspicious debut on the Hong Kong exchange, with a 12% decline in price on the heels of its $512 million offering. Report

> Par Pharmaceutical bought the rights to sell generic Seroquel XR from Handa Pharmaceuticals, which believes it's entitled to 180-day exclusivity as the first to file for FDA approval. Report

> Korean drugmakers Keuwha Pharmaceutical and Hondok Pharmaceutical rose on an updraft of M&A speculation, as investors look for buyout targets in the consolidating sector. Report

Medical Device News

 @FierceMedDev: Ariste Medical raised $1.275M in seed money to advance development of a drug-coated vascular graft. More | Follow @FierceMedDev

 @MarkHFierce: CryoLife celebrates 13% revenue jump in Q3. More | Follow @MarkHFierce

 @DamianFierce: Orthofix pays $32M to settle allegations it gave kickbacks--including parties with strippers & prostitutes--to docs. More | Follow @DamianFierce

> Report: Global neuromodulation device market ripe for double-digit growth. Item

> Medtronic looks to unseat Edwards with heart valve. Report

Biotech News

 @FierceBiotech: Alzheimers investigators see fresh sign of solanezumab success in $LLY study. More | Follow @FierceBiotech

 @JohnCFierce: Biotech companies out there. You have any bad news to report? Do it now. Take advantage of the perfect storm to confess your sins quietly. | Follow @JohnCFierce

 @RyanMFierce: Focusing on hoped-for launch of tivozanib, $AVEO is axing 45 jobs or 17% of workers, eliminating 30 openings. More | Follow @RyanMFierce

> Cigarette maker Philip Morris rolls vaccine interests into China. Story

> Financial woes reduce AstraZeneca's industry profile. Item

> Theratechnologies once again tries to slash its way to breakeven point. Article

Pharma Manufacturing News

> Boehringer again doubling capacity at inhaler plant. Report

> Patheon will pick up four plants with Banner buyout. News

> Congressional report calls for FDA to regulate large compounders. Article

> Drugmakers close plants ahead in face of Hurricane Sandy. Item

Biotech Research News

> Wisconsin company to provide stem cells for NIH research. Story

> Roche drug, microRNA treatment conquered head and neck cancer cells. News

> Baker's yeast yields possible Lou Gehrig's disease drug target. Article

> Duke team builds viable cartilage from induced pluripotent stem cells. Report

And Finally... Perfectionist? Don't blame your parents, blame their genes, a study finds. Report

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.